PFIZER INC.
PFE US7170811035
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 67% | -7% | -41% | -5% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Damico Jennifer B. SR VP |
25.93 USD |
2,500 Sold |
64,825 USD |
27/02/2025 | 04/03/2025 |
| Blaylock Ronald E |
25.65 USD |
19,457 Bought |
499,072 USD |
13/02/2025 | 13/02/2025 |
| Gottlieb Scott |
28.24 USD |
1,000 Bought |
28,240 USD |
30/10/2024 | 30/10/2024 |
| Damico Jennifer B. SR VP |
28.66 USD |
5,154 Sold |
147,714 USD |
13/08/2024 | 13/08/2024 |
| Gottlieb Scott |
26.47 USD |
3,000 Bought |
79,401 USD |
15/12/2023 | 15/12/2023 |